A. M. Calafat, X. Ye, L. Wong, J. A. Reidy, and L. L. Needham, Exposure of the U.S. Population to Bisphenol A and 4-tertiary-Octylphenol, Environ. Health Perspect, vol.116, pp.39-44, 2003.

D. A. Haines and J. Murray, Human biomonitoring of environmental chemicals-early results of the 2007-2009 Canadian Health Measures Survey for males and females, Int. J. Hyg. Environ. Health, vol.215, pp.133-137, 2012.

A. Covaci, Urinary BPA measurements in children and mothers from six European member states: Overall results and determinants of exposure, Environ. Res, vol.141, pp.77-85, 2015.

, Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: Opinion on BPA, EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), vol.13, p.3978, 2015.

N. J. Cabaton, Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice, Environ. Health Perspect, vol.119, pp.547-552, 2011.

L. N. Vandenberg, Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice, Reprod. Toxicol. Elmsford N, vol.26, pp.210-219, 2008.

S. Patel, Bisphenol A Exposure, Ovarian Follicle Numbers, and Female Sex Steroid Hormone Levels: Results from a CLARITY-BPA Study, Endocrinology, 2017.

T. Corbel, Bisphenol A disposition in the sheep maternal-placental-fetal unit: mechanisms determining fetal internal exposure, Biol. Reprod, vol.89, p.11, 2013.

T. A. Patterson, Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys, Toxicol. Appl. Pharmacol, vol.267, pp.41-48, 2013.

C. Viguié, Maternal and fetal exposure to bisphenol a is associated with alterations of thyroid function in pregnant ewes and their newborn lambs, Endocrinology, vol.154, pp.521-528, 2013.

F. S. Vom-saal, Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures, Reprod. Toxicol. Elmsford N, vol.45, pp.105-116, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02640813

G. Gauderat, Bisphenol A glucuronide deconjugation is a determining factor of fetal exposure to bisphenol A, vol.86, pp.52-59, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02641312

G. Schönfelder, Parent bisphenol A accumulation in the human maternal-fetal-placental unit, Environ. Health Perspect, vol.110, pp.703-707, 2002.

W. Chou, Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan, Environ. Health Glob. Access. Sci. Source, vol.10, p.94, 2011.

, SCIENTIFIC REPoRTS |, vol.7

P. Fénichel, Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes, Hum. Reprod. Oxf. Engl, vol.27, pp.983-990, 2012.

R. R. Gerona, Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population, Environ. Sci. Technol, vol.47, pp.12477-12485, 2013.

T. Zhang, H. Sun, and K. Kannan, Blood and urinary bisphenol A concentrations in children, adults, and pregnant women from china: partitioning between blood and urine and maternal and fetal cord blood, Environ. Sci. Technol, vol.47, pp.4686-4694, 2013.

W. Dekant and W. Völkel, Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures, Toxicol. Appl. Pharmacol, vol.228, pp.114-134, 2008.

L. Aarons, Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed, Br. J. Clin. Pharmacol, vol.60, pp.581-583, 2005.

A. R. Maharaj and A. N. Edginton, Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development, CPT Pharmacomet. Syst. Pharmacol, vol.3, pp.1-13, 2014.

B. S. Shin, Physiologically based pharmacokinetics of bisphenol A, J. Toxicol. Environ. Health A, vol.67, pp.1971-1985, 2004.

J. G. Teeguarden, J. M. Waechter, H. J. Clewell, T. R. Covington, and H. A. Barton, Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach, Toxicol. Sci. Off. J. Soc. Toxicol, vol.85, pp.823-838, 2005.

A. N. Edginton and L. Ritter, Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model, Environ. Health Perspect, vol.117, pp.645-652, 2009.

J. W. Fisher, N. C. Twaddle, M. Vanlandingham, and D. R. Doerge, Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans, Toxicol. Appl. Pharmacol, vol.257, pp.122-136, 2011.

X. Yang, D. R. Doerge, J. G. Teeguarden, and J. W. Fisher, Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A, Toxicol. Appl. Pharmacol, vol.289, pp.442-456, 2015.

D. A. Sarigiannis, Integrated exposure and risk characterization of bisphenol-A in Europe, Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc, vol.98, pp.134-147, 2016.

K. A. Thayer, Pharmacokinetics of bisphenol A in humans following a single oral administration, Environ. Int, vol.83, pp.107-115, 2015.

J. A. Taylor, Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure, Environ. Health Perspect, vol.119, pp.422-430, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01137161

. Pharmacokinetics, , 1982.

S. H. Collet, Allometric scaling for predicting human clearance of bisphenol A, Toxicol. Appl. Pharmacol, vol.284, pp.323-329, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02637966

J. S. Barry and R. V. Anthony, The pregnant sheep as a model for human pregnancy, Theriogenology, vol.69, pp.55-67, 2008.

S. Kumar, Estimation of transplacental and nonplacental diphenhydramine clearances in the fetal lamb: the impact of fetal first-pass hepatic drug uptake, J. Pharmacol. Exp. Ther, vol.282, pp.617-632, 1997.

P. Ngamprasertwong, Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model, PloS One, vol.11, p.146563, 2016.

W. Völkel, T. Colnot, G. A. Csanády, J. G. Filser, and W. Dekant, Metabolism and kinetics of bisphenol a in humans at low doses following oral administration, Chem. Res. Toxicol, vol.15, pp.1281-1287, 2002.

T. Corbel, Bidirectional placental transfer of Bisphenol A and its main metabolite, Bisphenol A-Glucuronide, in the isolated perfused human placenta, Reprod. Toxicol. Elmsford N, vol.47, pp.51-58, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02636605

D. R. Doerge, N. C. Twaddle, K. A. Woodling, and J. W. Fisher, Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys, Toxicol. Appl. Pharmacol, vol.248, pp.1-11, 2010.

V. Gayrard, High bioavailability of bisphenol A from sublingual exposure, Environ. Health Perspect, vol.121, pp.951-956, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02645480

D. Guignard, Characterization of the contribution of buccal absorption to internal exposure to bisphenol A through the diet, Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc, vol.93, pp.82-88, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02637439

T. Corbel, Conjugation and deconjugation reactions within the fetoplacental compartment in a sheep model: a key factor determining bisphenol A fetal exposure, Drug Metab. Dispos. Biol. Fate Chem, vol.43, pp.467-476, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02641470

D. I. Edelstone, A. M. Rudolph, and M. A. Heymann, Liver and ductus venosus blood flows in fetal lambs in utero, Circ. Res, vol.42, pp.426-433, 1978.

K. Divakaran, R. N. Hines, and D. G. Mccarver, Human hepatic UGT2B15 developmental expression, Toxicol. Sci. Off. J. Soc. Toxicol, vol.141, pp.292-299, 2014.

G. Haugen, T. Kiserud, K. Godfrey, S. Crozier, and M. Hanson, Portal and umbilical venous blood supply to the liver in the human fetus near term, Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol, vol.24, pp.599-605, 2004.

P. L. Grigsby, Animal Models to Study Placental Development and Function throughout Normal and Dysfunctional Human Pregnancy, Semin. Reprod. Med, vol.34, pp.11-16, 2016.

A. Veiga-lopez, Gender-Specific Effects on Gestational Length and Birth Weight by Early Pregnancy BPA Exposure, J. Clin. Endocrinol. Metab, vol.100, pp.1394-1403, 2015.

J. Yamamoto, Quantifying bisphenol A in maternal and cord whole blood using isotope dilution liquid chromatography/ tandem mass spectrometry and maternal characteristics associated with bisphenol A, Chemosphere, vol.164, pp.25-31, 2016.

B. P. Smith, Confidence interval criteria for assessment of dose proportionality, Pharm. Res, vol.17, pp.1278-1283, 2000.

S. H. Collet, Estrogenicity of bisphenol a: a concentration-effect relationship on luteinizing hormone secretion in a sensitive model of prepubertal lamb, Toxicol. Sci. Off. J. Soc. Toxicol, vol.117, pp.54-62, 2010.

M. Z. Lacroix, Simultaneous quantification of bisphenol A and its glucuronide metabolite (BPA-G) in plasma and urine: applicability to toxicokinetic investigations, Talanta, vol.85, pp.2053-2059, 2011.

S. L. Beal, Ways to fit a PK model with some data below the quantification limit, J. Pharmacokinet. Pharmacodyn, vol.28, pp.481-504, 2001.

P. L. Bonate, Pharmacokinetic-Pharmacodynamic Modeling and Simulation, 2011.